908 Devices (MASS) Depreciation & Amortization (CF) (2020 - 2026)
908 Devices (MASS) reported Depreciation & Amortization (CF) of $1.1 million for Q1 2026, down 11.77% year-over-year from $1.3 million in Q1 2025, and up 2.52% on a QoQ basis from $1.1 million in Q4 2025.
908 Devices (MASS) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 11.77% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 7.15% YoY) and the FY2025 annual result came in at $4.5 million, down 4.63% from the prior year.
- Depreciation & Amortization (CF) improved to $1.1 million in Q1 2026 per MASS's latest filing, from $1.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.4 million in Q4 2024 and bottomed at $267000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $740000.0 (2023), against an average of $840235.3.
- The widest annual swing landed in 2023, when Depreciation & Amortization (CF) declined 29.81%; it then jumped 254.81% in 2024.
- Tracing MASS's Depreciation & Amortization (CF) over 5 years: stood at $577000.0 in 2022, then fell by 29.81% to $405000.0 in 2023, then jumped by 254.81% to $1.4 million in 2024, then decreased by 22.69% to $1.1 million in 2025, then increased by 2.52% to $1.1 million in 2026.
- Per Business Quant, the three latest MASS Depreciation & Amortization (CF) figures stand at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 972,000.00 |
| Jun 30, 2025 | 972,000.00 |
| Mar 31, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 504,000.00 |
| Jun 30, 2024 | 504,000.00 |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 405,000.00 |
| Dec 31, 2023 | 405,000.00 |
| Sep 30, 2023 | 740,000.00 |
| Sep 30, 2023 | 740,000.00 |
| Jun 30, 2023 | 605,000.00 |
| Jun 30, 2023 | 605,000.00 |
| Mar 31, 2023 | 634,000.00 |
| Mar 31, 2023 | 634,000.00 |
| Dec 31, 2022 | 577,000.00 |
| Dec 31, 2022 | 577,000.00 |
| Sep 30, 2022 | 459,000.00 |
| Sep 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 311,000.00 |
| Jun 30, 2022 | 311,000.00 |
| Mar 31, 2022 | 267,000.00 |
| Mar 31, 2022 | 267,000.00 |
| Dec 31, 2021 | 289,000.00 |
| Dec 31, 2021 | 289,000.00 |
| Sep 30, 2021 | 261,000.00 |
| Sep 30, 2021 | 261,000.00 |
| Jun 30, 2021 | 238,000.00 |
| Jun 30, 2021 | 238,000.00 |
| Mar 31, 2021 | 137,000.00 |
| Mar 31, 2021 | 137,000.00 |
| Dec 31, 2020 | 190,000.00 |
| Dec 31, 2020 | 190,000.00 |
| Sep 30, 2020 | 201,000.00 |
| Sep 30, 2020 | 201,000.00 |
| Jun 30, 2020 | 204,000.00 |
| Jun 30, 2020 | 204,000.00 |
| Mar 31, 2020 | 205,000.00 |
| Mar 31, 2020 | 205,000.00 |